Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.7M Buy
727,234
+310,668
+75% +$16.1M ﹤0.01% 2588
2025
Q4
$26.7M Buy
416,566
+151,040
+57% +$12.5M ﹤0.01% 2664
2025
Q3
$28.2M Buy
265,526
+100,676
+61% +$8.48M ﹤0.01% 2558
2025
Q2
$10.8M Buy
164,850
+114,114
+225% +$5.87M ﹤0.01% 3369
2025
Q1
$1.95M Sell
50,736
-45,161
-47% -$1.95M ﹤0.01% 4617
2024
Q4
$3.96M Buy
95,897
+26,197
+38% +$1.15M ﹤0.01% 4191
2024
Q3
$2.74M Buy
69,700
+65,227
+1,458% +$2.28M ﹤0.01% 4431
2024
Q2
$145K Buy
+4,473
New +$133K ﹤0.01% 5814

Other funds holding LIF

Morgan Stanley's LIF Position: Q1 2026 in Review

Morgan Stanley increased its Life360 (LIF) stake by 75% in Q1 2026, buying an estimated $16.1M and bringing the position to 727,234 shares worth $29.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2588.

Morgan Stanley first reported a position in LIF in Q2 2024 and has held it in 8 quarters since. 193 funds tracked by Wall St. Rank hold LIF as of Q1 2026.

  • Morgan Stanley held 727,234 shares of Life360 worth $29.7M as of Q1 2026.
  • Morgan Stanley bought 310,668 Life360 shares in Q1 2026, an estimated $16.1M.
  • Life360 made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2588 holding.
  • Morgan Stanley first reported a position in Life360 in Q2 2024 and has held it in 8 quarters since.
  • 193 funds tracked by Wall St. Rank held Life360 as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.